Cargando…

Prognostic value of imaging-based ATN profiles in a memory clinic cohort

PURPOSE: The ATN model represents a research framework used to classify subjects based on the presence or absence of Alzheimer’s disease (AD) pathology through biomarkers for amyloid (A), tau (T), and neurodegeneration (N). The aim of this study was to assess the relationship between ATN profiles de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peretti, Débora E., Ribaldi, Federica, Scheffler, Max, Chicherio, Christian, Frisoni, Giovanni B., Garibotto, Valentina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542279/ https://www.ncbi.nlm.nih.gov/pubmed/37358619 http://dx.doi.org/10.1007/s00259-023-06311-3

Ejemplares similares

ATN profile classification across two independent prospective cohorts
por: Peretti, Débora E., et al.
Publicado: (2023)

The taxonomy of subjective cognitive decline: proposal and first clinical evidence from the Geneva memory clinic cohort
por: Ribaldi, Federica, et al.
Publicado: (2023)

Brain connectivity and metacognition in persons with subjective cognitive decline (COSCODE): rationale and study design
por: Ribaldi, Federica, et al.
Publicado: (2021)

Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison
por: Altomare, Daniele, et al.
Publicado: (2021)

Unsupervised [(18)F]Flortaucipir cutoffs for tau positivity and staging in Alzheimer’s disease
por: Quattrini, Giulia, et al.
Publicado: (2023)

The Biological Substrate of the Motoric Cognitive Risk Syndrome: A Pilot Study Using Amyloid-/Tau-PET and MR Imaging
por: Bommarito, Giulia, et al.
Publicado: (2022)

Plasma biomarkers for Alzheimer’s disease: a field-test in a memory clinic
por: Altomare, Daniele, et al.
Publicado: (2023)

Association between ATN profiles and mortality in a clinical cohort of patients with cognitive disorders
por: Régy, Mélina, et al.
Publicado: (2023)

Prognostic value of amyloid/tau/neurodegeneration (ATN) classification based on diagnostic cerebrospinal fluid samples for Alzheimer’s disease
por: Delmotte, Koen, et al.
Publicado: (2021)

Exploring the ATN classification system using brain morphology
por: Heinzinger, Nils, et al.
Publicado: (2023)

Evaluation of the ATN model in a longitudinal memory clinic sample with different underlying disorders
por: Eckerström, C., et al.
Publicado: (2021)

Prognostic value of ATN Alzheimer biomarkers: 60‐month follow‐up results from the Argentine Alzheimer's Disease Neuroimaging Initiative
por: Allegri, Ricardo F., et al.
Publicado: (2020)

Longitudinal change in ATN biomarkers in cognitively normal individuals
por: Ebenau, Jarith L., et al.
Publicado: (2022)

Long-term surgical outcomes and prognostic factors of foveal detachment in pathologic myopia: based on the ATN classification
por: Feng, Jingyang, et al.
Publicado: (2022)

Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort
por: Ingala, Silvia, et al.
Publicado: (2021)

The association of serum uric acid with cognitive impairment and ATN biomarkers
por: Huang, Shan, et al.
Publicado: (2022)

Surgical Outcomes of Myopic Foveoschisis According to the ATN Classification System
por: Fang, Dong, et al.
Publicado: (2022)

Societal and equity challenges for Brain Health Services. A user manual for Brain Health Services—part 6 of 6
por: Milne, Richard, et al.
Publicado: (2021)

Sex differences in dementia with Lewy bodies: an imaging study of neurotransmission pathways
por: Boccalini, Cecilia, et al.
Publicado: (2023)

Head-to-head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints
por: Lu, Jiaying, et al.
Publicado: (2023)

VALIDATION OF THE RECENTLY DEVELOPED ATN CLASSIFICATION AND GRADING SYSTEM FOR MYOPIC MACULOPATHY
por: Ruiz-Medrano, Jorge, et al.
Publicado: (2020)

Longitudinal trajectories of Alzheimer’s ATN biomarkers in elderly persons without dementia
por: Tan, Meng-Shan, et al.
Publicado: (2020)

ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project
por: Ebenau, Jarith L., et al.
Publicado: (2020)

Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease
por: Duong, Michael Tran, et al.
Publicado: (2022)

YOLOv5-Atn: An Algorithm for Residual Film Detection in Farmland Combined with an Attention Mechanism
por: Lin, Ying, et al.
Publicado: (2023)

Biomarkers to Evaluate Androgen Deprivation Therapy for Prostate Cancer and Risk of Alzheimer’s Disease and Neurodegeneration: Old Drugs, New Concerns
por: Achard, Vérane, et al.
Publicado: (2021)

Functional imaging studies of cognition using (99m)Tc-HMPAO SPECT: empirical validation using the n-back working memory paradigm
por: Ludwig, Catherine, et al.
Publicado: (2007)

Renal outcomes according to renal replacement therapy modality and treatment protocol in the ATN and RENAL trials
por: Naorungroj, Thummaporn, et al.
Publicado: (2022)

The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection
por: Beddingfield, Brandon J., et al.
Publicado: (2020)

uPAR antibody (huATN-658) and Zometa reduce breast cancer growth and skeletal lesions
por: Mahmood, Niaz, et al.
Publicado: (2020)

Penta-peptide ATN-161 based neutralization mechanism of SARS-CoV-2 spike protein
por: Rabbani, Gulam, et al.
Publicado: (2021)

Anomalous kinetic study of atenolol release from ATN@DNA a core-shell like structure
por: Hefny, Mohamed Mokhtar, et al.
Publicado: (2023)

Identification of preclinical dementia according to ATN classification for stratified trial recruitment: A machine learning approach
por: Koychev, Ivan, et al.
Publicado: (2023)

Prediction of Alzheimer’s disease biomarker status defined by the ‘ATN framework’ among cognitively healthy individuals: results from the EPAD longitudinal cohort study
por: Calvin, Catherine M., et al.
Publicado: (2020)

The Clinical Use of Alzheimer’s Disease Biomarkers in Patients with Mild Cognitive Impairment: A European Alzheimer’s Disease Consortium Survey
por: Caprioglio, Camilla, et al.
Publicado: (2022)

Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224)
por: Doñate, F, et al.
Publicado: (2008)

The copper chelator ATN-224 induces caspase-independent cell death in diffuse large B cell lymphoma
por: LEE, KRISTY, et al.
Publicado: (2014)

Co-expression Patterns between ATN1 and ATXN2 Coincide with Brain Regions Affected in Huntington’s Disease
por: Keo, Arlin, et al.
Publicado: (2017)

Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife
por: Kritikos, Minos, et al.
Publicado: (2020)

Dynamic changes of CSF sPDGFRβ during ageing and AD progression and associations with CSF ATN biomarkers
por: Wang, Jun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qtogo3818p66k8hr26coc0740u